ProKidney Corp is a clinical-stage biotechnology company developing proprietary cell therapy platforms to treat chronic kidney diseases, aiming to preserve kidney function and delay or prevent dialysis or transplant.

ProKidney Logo

About ProKidney

ProKidney Corp is a clinical-stage biotechnology company focused on developing proprietary cell therapy platforms for the treatment of chronic kidney diseases. Its lead product, Renal Autologous Cell Therapy (REACT), is designed to repair and restore diseased kidneys using a patient’s own cells, with the goal of preserving kidney function and potentially delaying or eliminating the need for dialysis or transplant. ProKidney’s therapies are in advanced clinical trials and aim to address significant unmet needs in chronic kidney disease care.

Address

2000 Frontis Plaza Blvd., Suite 250
Winston-Salem, 27103
United States

Year founded

2021

Number of employees

100-200

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Report inaccurate data

Request an update to help us keep the brand up-to-date.

One API,
Millions of Logos

Get Started Contact Us
One API, Millions of Logos